Home -> Law Blog Directory -> Patent Law Blogs -> Philip Brooks’ Patent Infringement Updates
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Patent Law
: Philip Brooks’ Patent Infringement UpdatesMylan Settles Patent Dispute with Schering-Plough Over Clarinex
By Philip Brooks
From the April 9, 2009 issue of The Pittsburgh Tribune-Review:
Mylan Inc. announced a patent litigation settlement with Schering-Plough concerning its generic version of the Clarinex allergy medication, a case pending in federal court for 2 1/2 years.
Under the settlement, Canonsburg-based Mylan can market its generic Desloratadine tablets in the 5-milligram size in the United States beginning July 1, 2012, with U.S. Food and Drug Administration approval.
No further settlement details were made public.
Full post as published by Philip Brooks’ Patent Infringement Updates on April 10, 2009 (boomark / email).
Schering Plough, Merck
Settle Multi-State Investigation for $5.4 Million
Zantac Patent
GlaxoSmithKline and Cypress Pharmaceutical settle patent infringement dispute.
Qualcomm Settles Patent Suit for $891 Million
Soliris Patent
Alexion Pharmaceuticals Inc. agrees to pay the Oklahoma Medical Research Foundation a $10 million patent infringement settlement.
Perdidas Por Planes de Ahorro de Empleados de Schering
DRAM Patent
ProMOS Technologies and Mosel Vitelic pay MOSAID Technologies an undisclosed patent infringement settlement.

Dr. Reddy's settles with Schering over Clarinex
GeoPharma does deal with Schering over Clarinex
FTC v. Schering-Plough: DOJ Opposes Cert
Merck and Schering-Plough to Merge
Skaddens Washington Office Gets a Piece of Merck, Schering-Plough Merger









